Don’t invest unless you’re prepared to lose all the money you invest. This is a high‑risk investment and you are unlikely to be protected if something goes wrong. Take 2 mins to learn more.

BIA talk

Erebagen at BIA Women in Biotech

This week, Erebagen CEO and Chair, Fiona Marston, took part in a panel discussion at the BIA's Women In Biotech event.

It was fantastic to see so many brilliant women joining the BIA’s Women in Biotech session. Among them was Fiona Marston OBE, PhD, CEO & Chair of portfolio company Erebagen – who are using nature’s resources to discover, optimise and scale novel bioactives by harnessing silent gene clusters.

Fiona took part in a panel on Redefining Sector Leadership – picking up on the International Women’s Day theme of #InspireInclusion. Reflecting on her experience at the conference, Fiona shared how inspiring it was to be in a setting with predominantly female attendees and to hear amazing opening talks from Harriet Oppenheimer (RNID) and ex-Olympian Michelle Griffith Robinson OLY.

She said: “It was an honour to share a platform with a group of remarkable women leaders. In our panel session we had an open, honest dialogue about female leadership, sharing our experience of how to overcome challenges and succeed.

“It was fantastic to see the engagement and participation from the audience and to inspire inclusion through this event. The conversations throughout the day were impactful and I have no doubt that the connections people made will have long-lasting benefit.”

Find out more about Erebagen: